![Big data emphasis underpins Teva's plans for smart inhaler, clinical trial innovations | MobiHealthNews Big data emphasis underpins Teva's plans for smart inhaler, clinical trial innovations | MobiHealthNews](https://www.mobihealthnews.com/sites/default/files/Teva%20Dr.%20Lena%20Granovsky.jpg)
Big data emphasis underpins Teva's plans for smart inhaler, clinical trial innovations | MobiHealthNews
![Shlomo Yanai, Teva's president and chief executive, addresses the media during a news conference in Tel Aviv July 27, 2010. Teva Pharmaceutical Industries, the world's largest generic drugmaker, reported higher quarterly net Shlomo Yanai, Teva's president and chief executive, addresses the media during a news conference in Tel Aviv July 27, 2010. Teva Pharmaceutical Industries, the world's largest generic drugmaker, reported higher quarterly net](https://c8.alamy.com/comp/2D1M57M/shlomo-yanai-tevas-president-and-chief-executive-addresses-the-media-during-a-news-conference-in-tel-aviv-july-27-2010-teva-pharmaceutical-industries-the-worlds-largest-generic-drugmaker-reported-higher-quarterly-net-profit-on-tuesday-boosted-by-sales-of-generic-medicines-and-its-own-branded-multiple-sclerosis-treatment-copaxone-reutersnir-elias-israel-tags-business-2D1M57M.jpg)
Shlomo Yanai, Teva's president and chief executive, addresses the media during a news conference in Tel Aviv July 27, 2010. Teva Pharmaceutical Industries, the world's largest generic drugmaker, reported higher quarterly net
![Teva & Tel Aviv University Sign a Collaboration Agreement - Strategic Partnering - Strategic Partnering Teva & Tel Aviv University Sign a Collaboration Agreement - Strategic Partnering - Strategic Partnering](http://strategic-partnering.net/wp-content/uploads/2020/01/teva25Nov.jpg)